NEW YORK CITY (PIX11) — Whether you’re a kid or a parent looking for things to do in the city this summer, New York City Mayor Zohran Mamdani is making it a little easier to find activities that won’t ...

Two Bristol Myers Squibb (BMS) researchers at work. BMS will partner with Hengrui Pharma to co-develop 13 early-stage programs in oncology, hematology and immunology, the companies said today, through ...

Throughout the year, a lot of tools pass through our hands in the Popular Mechanics workshop. These tools run the gamut, with many just launched, brand new models, while others that are simply new to ...

Under a 2025 law, the Department of Veterans Affairs can advance funds to cover a veteran’s missed VA loan payments and bring the loan current. (Steven Senne/AP) When the Department of Veterans ...

Treating chronic diseases can involve intensive programs designed to change people’s diet, exercise and other health behaviors. But a typical program, while packed with information and advice, may ...

Claude Code isn’t the quickest or cheapest AI coding tool, but it may be the smartest. It automates code review and security checks before sending code live, and developers say the tool is uniquely ...

A select panel of L.A. County judges now have access to an artificial intelligence tool that can help them summarize motions and draft rulings in civil court. The tool, Learned Hand, is already in use ...

March 10 (Reuters) - OpenAI plans to soon launch its AI video generator Sora in ChatGPT, The Information reported ‌on Tuesday, citing people familiar with the matter. Sign up here. While text-centric ...

Social media companies are under pressure to crack down on so-called deepfake videos that use deceptive images of real people. By Natallie Rocha Reporting from San Francisco YouTube is adding a ...

New York, NY, December 5, 2025 — The International Rescue Committee (IRC) today announced the public launch of SCALE – Scenario Costing and Analysis for Large-scale Efficiency in Nutrition, an ...

Bristol Myers Squibb is shedding two clinical programs from its in-house pipeline, one from its 2023 Mirati buyout and another from a partnership with U.K. biotech Exscientia, now known as Recursion.

On the heels of the launch of an online direct-to-patient (DTP) program offering discounted Eliquis to certain U.S. patients, Bristol Myers Squibb is putting Sotyku at the center of its next DTP ...